Researchers are increasingly examining retatrutide, a innovative medication from Eli Lilly, as a potential breakthrough in physique loss . Distinct from many previous approaches, retatrutide is a double -action receptor targeting equally GLP-1 and GIP, substances that influence appetite and blood gl